Dental Bone Graft Substitutes Market Report 2025

This report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The dental bone graft substitutes market size has grown strongly in recent years. It will grow from $4.15 billion in 2024 to $4.45 billion in 2025 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to increasing dental procedures, rising dental restoration needs, expanding aging population, increase in cosmetic dentistry procedures, preference for minimally invasive dentistry, patient demand for aesthetic solutions.

The dental bone graft substitutes market size is expected to see strong growth in the next few years. It will grow to $5.56 billion in 2029 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to growing emphasis on preventive dentistry, increasing demand for implant dentistry, focus on bioactive and biomimetic materials, expansion of dental tourism, shift towards holistic and patient-centric dentistry. Major trends in the forecast period include application of digital impression technology in cementation, development of color-matching technology in resin cements, introduction of fast-setting and high-viscosity cements, emphasis on adhesive cements with low post-operative sensitivity, focus on self-etching and selective etching techniques.

The increasing prevalence of dental disorders is expected to drive the growth of the dental bone graft substitute market in the coming years. Dental disorders encompass various medical conditions affecting the oral cavity, including teeth, gums, and surrounding structures. Dental bone graft substitutes are critical in treating these disorders, as they address bone deficiencies in the jaw and facilitate dental implant placement. By transplanting bone tissue to the affected area, these substitutes provide the necessary structure for new bone growth. For instance, a March 2023 report from the World Health Organization indicated that approximately 3.5 billion people globally suffered from oral diseases in 2022, with caries affecting around 2 billion adults and 514 million children. This rising prevalence of dental disorders underscores the growing demand for dental bone graft substitutes in dental treatments.

The growing elderly population is expected to propel the dental bone graft substitute market forward. The elderly population comprises individuals who are advanced in age or considered seniors. Dental bone graft substitutes play a crucial role in addressing the specific dental needs of the elderly, contributing to improved oral health and overall quality of life for aging individuals. As of July 2023, a report by Age UK, a UK-based registered charity, stated that England has 11 million individuals aged over 65, projected to increase by 10% in the next five years and by 32% by 2043. The population aged 85 and above is expected to rise by 8.2% in the next five years and by 62.7% by 2043, reaching 2.8 million. Therefore, the growing elderly population is a significant factor driving the growth of the dental bone graft substitute market.

Major companies in the dental bone graft substitute market are focusing on developing innovative products such as regenerOss CC allograft particulate and regenerOss bone graft plug to enhance their services. RegenerOss CC allograft particulate is a dental bone graft substitute material containing a natural blend of cortical and cancellous bone particles to promote bone regeneration in the oral cavity. RegenerOss bone graft plug is a solution for filling extraction sockets and periodontal defects. For example, in April 2023, ZimVie Inc., a US-based medical instrument manufacturing company, introduced RegenerOss CC Allograft Particulate and RegenerOss Bone Graft Plug, designed for minimally invasive procedures that can be performed in an office setting. These products, made from bovine bone, offer a safe and effective way to repair or reconstruct the jaw, applicable in various dental applications.

In July 2022, Envista Holdings Corporation, a U.S.-based dental equipment and supplies manufacturer, acquired Osteogenics Biomedical Inc. for an undisclosed amount. This strategic acquisition aims to enhance Envista's capabilities in regenerative therapies and implant dentistry, particularly focusing on innovative solutions designed for periodontists and oral surgeons. Osteogenics Biomedical specializes in developing cutting-edge dental bone grafting products tailored for periodontists, oral and maxillofacial surgeons, and clinicians in the field of implant dentistry. This move is expected to strengthen Envista's product offerings and position in the growing dental bone graft substitute market, ultimately improving patient outcomes in dental procedures.

Major companies operating in the dental bone graft substitutes market report are Johnson and Johnson Services Inc., Stryker Corporation, Medtronic PLC, Zimmer Biomet Holdings Inc., Smith and Nephew PLC, Dentsply Sirona, Straumann Group, ZimVie Inc., Wright Medical Group N.V., LifeNet Health, RTI Surgicals Inc., Dentium Co. Ltd., Orthofix Medical Inc., BioHorizons Inc., Keystone Dental Inc., Geistlich Pharma AG, MIS Implants Technologies Ltd., Sunstar Group, Collagen Matrix Inc., OsteoMed LLC, Ace Surgical Supply Co. Inc., Salvin Dental Specialties Inc., Osteogenics Biomedical Inc., Botiss biomaterials GmbH, Curasan Inc., Novabone Products LLC, Biomatlante S.A, Carmell Therapeutics Corp., Neobiotech Co. Ltd., Silfradent S.r.l.

North America was the largest region in the dental bone graft substitutes market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dental bone graft substitutes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the dental bone graft substitutes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The dental bone graft substitutes market consists of sales of demineralized bone matrix (DBM), ceramic-based bone grafts, calcium sulfate bone grafts, and synthetic bone graft substitutes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

Dental bone graft substitutes are biocompatible substances utilized in oral and maxillofacial surgery to facilitate bone regeneration and restore lost or damaged bone tissue in the jaw or oral cavity. These substitutes are typically employed when a patient lacks sufficient natural bone volume or density, often due to tooth extraction, periodontal disease, trauma, or other dental conditions.

The primary types of dental bone graft substitutes include xenograft, allograft, autograft, and others. A xenograft dental bone graft substitute encompasses various materials, such as hydroxyapatite, tricalcium phosphate, calcium phosphate, and others. These materials operate through mechanisms such as osteoconduction, osteoinduction, osteogenesis, and osteopromotion. They find applications in ridge augmentation, sinus lift, socket preservation, and addressing periodontal defects. End users of these substitutes include hospitals, dental clinics, and other healthcare facilities.

The dental bone graft substitutes market research report is one of a series of new reports that provides dental bone graft substitutes market statistics, including dental bone graft substitutes industry global market size, regional shares, competitors with dental bone graft substitutes market share, detailed dental bone graft substitutes market segments, market trends and opportunities, and any further data you may need to thrive in the dental bone graft substitutes industry. This dental bone graft substitutes market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.